Summary The obesity-BMD relationship is complex. In 3045 middle-aged adults, we found that in women (but not men) with discordant fat mass index (FMI)/BMI categories, higher body fat for BMI was associated with lower BMD, suggesting that increased fat mass without an accompanying increase in lean mass may be deleterious to bone. Introduction The relationship between obesity and BMD is complex. FMI (fat mass (kg) / height (m) 2 ) is a more accurate measure of fatness than BMI, and depending on body composition, some individuals have discordant BMI/FMI categories. We examined associations between FMI, BMI and BMD in participants in the Busselton Healthy Ageing Study. Methods Body composition and BMD of the hip, spine and total body were measured using DXA in 3045 participants (1644 females) aged 45-67 years. Using standard BMI/FMI categories, the participants were classified as underweight/fat deficit, normal, overweight/ excess fat, obese I and obese II-III. Results BMI and FMI categories were concordant in 77.3 % of females and 71.2 % of males. There were 12.9 % females and 13.2 % males in a higher FMI than BMI category (high body fat for BMI), whereas 9.8 % females and 15.6 % males were in a lower category (low body fat for BMI). Females with high body fat for BMI had significantly lower covariate-adjusted BMD at the femoral neck, total hip and total body (differences of 3.8, 5.1 and 2.6 %, respectively, all P < 0.05) than females with low body fat for BMI and lower total body BMD than women with concordant FMI/ BMI (by 1.4 %, P = 0.04). In males, BMD did not differ significantly between those who were concordant or discordant for FMI/BMI categories. Conclusion In women (but not men) with discordant FMI/ BMI categories, higher body fat for BMI was associated with lower BMD, suggesting that increased fat mass without an accompanying increase in lean mass may be deleterious to bone.
Introduction
Obesity is a serious public health problem, and the relationship between obesity and bone health is complex. While body weight and body mass index (BMI) have been shown to positively correlate with bone mineral density (BMD) and bone mineral content (BMC) in linear regression analyses [1, 2] , there is also evidence that obesity may not be protective against osteoporosis and may even be detrimental to bone health [3, 4] . In a large, population-based study of 832,775 post-menopausal women classified by BMI categories, the rate of hip and pelvis fractures was significantly lower in overweight and obese women than in women with normal or low BMI, but proximal humerus fractures were significantly more common in obese women than normal/underweight women [5] . Furthermore, in women who sustained hip, clinical spine or pelvic fractures, this occurred at a significantly younger age in obese women than in women with normal or low BMI [5] . In a study of 5025 men and women aged 47-50 and 71-75 years, it was found that in women, the association between fat mass and femoral neck BMD was weaker in participants with fat mass above the population median (22.2 kg) compared with those with fat mass below the median [6] . Furthermore, in a recent study of 176 women aged 18-45 years, vertebral strength estimated from quantitative computed tomography (QCT) measurements was related to BMI in an inverted U shape, with a negative association between BMI and estimated vertebral strength in obese women, who also had a higher predicted vertebral fracture risk than lean controls in several biomechanical models (standing, holding and lifting weights) [7] .
Body weight and BMI are convenient measurements for clinical epidemiology, but they do not separate fat mass from lean mass. Linear regression models have been used to evaluate the relationships of lean and fat mass (as measured by dual-energy X-ray absorptiometry (DXA)) with BMD and have provided important information on the independent significance of lean and fat mass [8] [9] [10] [11] [12] [13] [14] [15] but could not determine the influence of excess body fat relative to body size (as reflected by BMI) on bone health. The use of body fat percentage as a measure of body fatness is also likely to be confounded by lean body mass, because at the same fat mass, body fat percentage decreases with increased lean mass [16] . It has been proposed to establish different healthy body fat percentage ranges for each BMI category of underweight, overweight and obesity [17] . In recent years, fat mass index (FMI, fat mass in kg / height in m 2 ) has been suggested to be a more accurate indicator of body fatness than BMI, as it is independent of other body components such as lean mass. The classification ranges for fat deficit, normal, excess fat and obese classes I to III have been developed from the data collected in the American National Health and Nutrition Examination Survey (NHANES) [16] . Since both lean mass and fat mass contribute to body mass and thus to BMI, some individuals have discordant BMI and FMI categories, depending on their body composition. For example, if an increase in fat mass was not accompanied by a proportional increase in lean mass, that individual would have higher FMI than BMI category.
In a previous analysis of participants in the Busselton Healthy Ageing Study, we found positive relationships between each of lean mass or fat mass with BMD. However, in participants with higher BMI (based on tertiles), these relationships were attenuated in females and absent in males [18] . The aim of the present study was to examine further the relationship between body fatness and BMD, using the discordance between FMI and BMI classifications as a tool to identify subjects with higher or lower FMI for BMI categories and to investigate the influence of body fatness in relation to BMI on BMD in middle-aged adults.
Participants and methods

Participants
The Busselton Healthy Ageing Study is a study of noninstitutionalised 'baby boomers' (defined as those born from 1946 to 1964) resident in the Shire of Busselton, Western Australia, a coastal town in south-western Australia with a predominantly white population. The design and rationale of the study have been previously described [19] . All eligible residents listed on the electoral roll have been invited to participate; electoral registration is compulsory in Australia. Phase 1 of the study comprises a cross-sectional health survey and will be followed by longitudinal studies. Between May 2010 and June 2013, 3150 participants were recruited to the study for the baseline survey (comprising ∼80 % of those eligible) and, of these, 3080 had a DXA examination. After excluding 35 of non-Caucasian ethnicity, 3045 participants (1401 males and 1644 females) were included in this analysis. The study received the ethics approval from the University of Western Australia Human Research Ethics Committee (number RA/4/1/2203), and written informed consent was obtained from each participant.
DXA scans
DXA scans were undertaken to assess the BMD of the total hip, femoral neck, anterior-posterior spine (L1-L4) and whole body using a GE Lunar Prodigy Pro densitometer (Madison, WI, USA). The scans were analysed using enCORE version 13 (GE Health) software with manual inspection of regions of interest and adjustment where necessary by two independent reviewers (MH and KZ). Body composition estimates including whole body fat mass (g) and lean mass (bone free) (g) were also obtained from the whole body DXA scan. FMI was calculated as fat mass (kg) / height (m 2 ), and lean mass index (LMI) was calculated as lean mass (kg) / height (m 2 ). Percentage body fat mass was calculated as (fat mass / total mass) × 100. Annual servicing and calibration according to the manufacturer's specifications were carried out, and calibration of the DXA machine using a phantom was performed prior to each scanning session. The precision error was <2.0 % for each measured site at a standard speed based on repeated scans in a random sample of 30 subjects. Using FMI reference ranges developed from the NHANES, the participants were classified into categories of fat deficit, normal, excess fat, obese I and obese II-III using FMI cut-offs of <3, 3-6, 6-9, 9-12 and >12 for males and <5, 5-9, 9-13, 13-17 and >17 for females [16] .
Other assessments
Standing height and body weight were measured using standard anthropometric techniques with the participants lightly clothed and shoeless. BMI was calculated as weight (kg) / height (m) 2 . The BMI between 18.5 and 24.99 kg/m 2 was regarded as normal, <18.5 underweight, 25-29.99 overweight, 30-34.99 obese I and ≥35 obese II-III according to the WHO criteria [20] . Data on health history, medication use and smoking habit (current, never or previous smokers) were collected using a questionnaire [19] . The questionnaire did not collect information on dietary history, such as calcium and protein intake, but included a question regarding avoidance of dairy products. Physical activity level was assessed using the International Physical Activity Questionnaire (IPAQ) and categorised as low, medium and high according to the IPAQ scoring protocol [21] . Fasting blood samples were collected, and serum 25-hydroxyvitamin D (25-OHD) was measured using the Architect 25-OH vitamin D assay (Abbott Laboratories, Abbott Park, IL, USA). One hundred and seventeen samples (randomly selected within three strata of 25-OHD) were also assayed using isotope dilution liquid chromatography/tandem mass spectrometry (LC-MS/MS) according to the published methodology [22] , and there was a strong correlation between the two techniques (r 2 = 0.88).
Data analysis
Variables are presented as means ± standard deviations (SDs) or means ± standard error of mean (SEM) for adjusted values by gender unless otherwise stated. Generalised additive models (GAMs), which offer a greater flexibility to represent the relations between the dependent variable and predictor variables compared with linear regression, were used to generate graphic representations of the dose-response relations of each of FMI and BMI with BMD in each gender, adjusted for the following covariates: age, LMI (for the models for FMI only), smoking, alcohol consumption (≥3 units/day), smoking history (never/past/current), serum 25-OHD, physical activity level and dairy avoidance. Comparisons between the three groups, low body fat for BMI (refers to those with lower FMI than BMI category), concordant FMI and BMI and high body fat for BMI (refers to those with higher FMI than BMI category), were made by analysis of variance (ANOVA) with Tukey's post hoc test and analysis of covariance (ANCOVA) adjusted for covariates listed above for GAMs (except for LMI) with Bonferroni post hoc test. The normality and independence of the residuals and the homogeneity of variance of each model were checked using residual plots (normal probability plot and plot of residuals vs predicted values). Statistical significance level was set at P < 0.05 (two-tailed). All analyses were performed using IBM SPSS (version 22; IBM, Chicago, IL, USA) and R (version 3.0.1; R Foundation for Statistical Computing, Vienna, Austria).
Results
Demographic details and key clinical data for all participants are shown in Table 1 . The mean age of the participants was 56.9 ± 5.6 years (range 45.5-67.3) for males and 56.5 ± 5.5 years (range 45.7-67.2) for females. Although males had slightly but significantly higher BMI compared with females (28.4 ± 4.0 vs 27.8 ± 5.4 kg/m 2 , P < 0.001), they had significantly lower FMI (8.1 ± 2.9 vs 11.4 ± 4.2, P < 0.001). According to BMI categories, the prevalence rates of overweight, obese I and obese II-III are 53.4, 22.6 and 6.8 % in males and 35.4, 19.9 and 9.9 % in females, respectively. Males had significantly higher height, body weight, LMI, serum 25-OHD and BMD at the hip, femoral neck, spine and total body and significantly lower percentage body fat compared with females. Males were also more likely to be current or past smokers, to consume 3 units or more of alcohol per day and to have higher physical activity level. Figure 1 shows the breakdown of male and female participants according to five categories of BMI and FMI. BMI and FMI categories were concordant in 71.2 % of males and 77.3 % of females. In females, 9.8 % were in a lower FMI than BMI category (low body fat for BMI), whereas 12.9 % were in a higher category (high body fat for BMI). For males, the corresponding figures were 15.6 and 13.2 %. Figure 2 depicts the dose-response relations of each of BMI and FMI with BMD in each gender using the generalised additive models. For BMI, a positive relationship with BMD at each site is apparent in both males and females, but the associations at each site appear weaker at higher values of BMI. For FMI, there is a positive relationship with BMD at all sites across all FMI values in males, whereas in females, BMD increases with FMI till FMI reaches about 20 kg/m 2 , after which there is an apparent decline in BMD at the femoral neck, total hip and total body. In post hoc partial correlation analyses (adjusted for age and LBM) in females with FMI ≥20 kg/m 2 (n = 50), FMI negatively associated with total hip BMD (r = 0.290, P = 0.037) and had no significant correlations with total body, spine or femoral neck BMD (r = −0.230 to −0.070, P > 0.05). It should be noted that because of the higher prevalence of obese II-III and the higher FMI values in female participants compared with males, the values on the x-axes differ between genders. In addition, the models in females explained a higher percentage of variance in BMDs (adjusted R 2 0.133-0.236) compared with the models in males (adjusted R 2 0.057-0.136). Table 2 shows the comparison of characteristics between participants with higher, concordant or lower FMI for BMI category. Males with low body fat for BMI were younger and had lower body weight and BMI and higher serum 25-OHD concentrations compared with males with concordant FMI/BMI or high body fat for BMI. Females with low body fat for BMI were younger and shorter compared with those who had high body fat for BMI. In both genders, participants with low body fat for BMI were more likely to have a high physical activity level. Table 3 shows the comparison of BMD between those with higher, concordant or lower FMI for BMI categories. In males, there were no significant BMD differences between the three groups in either the unadjusted or the covariate-adjusted analyses. In females, in the unadjusted analysis, those with high body fat for BMI had significantly lower femoral neck, total hip and total body BMD compared with those with concordant FMI and BMI (differences 2.5, 3.0 and 1.6 %, respectively) and low body fat for BMI (5.2, 6.1 and 3.0 %, respectively) (all P < 0.05), but not spine BMD. In addition, those with Values are mean ± SD unless otherwise stated a Student's t test or chi-square test concordant FMI and BMI had significantly lower total hip BMD compared with those with low body fat for BMI (3.0 %, P = 0.03). After adjustment for age, smoking, alcohol consumption, serum 25-OHD, physical activity level and dairy avoidance, BMD differences at the femoral neck, total hip and total body remained significant between women with high and low body fat for BMI (adjusted differences 3.8, 5.1 and 2.6 %, respectively, all P < 0.05), as did whole body BMD differences between women with high body fat for BMI and concordant FMI/BMI (1.4 %, P = 0.04).
Discussion
In this community-based study of middle-aged individuals, we found that when participants were categorised according to BMI and FMI, there was discordance in 29 % of males and 23 % of females, such that 10 % of males and 13 % of females had a higher fat mass (by FMI criteria) than predicted by BMI.
After adjustment for relevant covariates, females with high body fat for BMI had significantly lower BMD at the femoral neck, total hip and total body than women with low body fat for BMI and lower total body BMD than women who were concordant for FMI/BMI. In men, however, BMD did not differ significantly between groups based on FMI/BMI discordance. The role of body composition on bone health has been extensively researched, but findings on the effect of fat mass on BMD have been controversial. This could be largely due to the inter-correlation of body weight, lean mass and fat mass, and the complex relationships of obesity and bone, including the positive impact of mechanical loading and the negative impact of excess body fat on bone metabolism. Our study used the discordance between FMI and BMI classifications as a tool to identify subjects with excess or low body fat relative to BMI, since if an increase in fat mass is accompanied by a proportional increase in lean mass, FMI and BMI categories would be concordant. Our study suggests that increased fat mass, without an accompanying increase in lean mass (as reflected in FMI/BMI discordance), may have detrimental effects on BMD at the femoral neck, total hip and total body in middle-aged women. Consistent with this, in a previous study of 4489 white participants aged 19 to 90 years, in each BMI category (18.5-25, 25-30 and >30 kg/m 2 ), total body BMC decreased with increased body fat percentage quartiles [3] . In a large study of 7137 Chinese men and 6833 women aged 25-64 years, fat mass was negatively associated with whole body and total hip BMC across 5 kg strata of body weight [23] . In our study, we did not observe differences in lumbar spine BMD between the different FMI for BMI categories. Previous studies have shown that obese individuals are more prone to have fractures at appendicular bones such as the ankle, lower limb and humerus [5, 24] ; thus, it is possible that cortical bone rather than trabecular bone is preferentially affected by obesity.
There are several possible mechanisms by which obesity could have a negative impact on bone health. Firstly, obesity and osteoporosis could have shared genetic determinants, as several shared genomic regions for body fat mass and BMD have been identified using bivariate whole-genome linkage scan [25] . Secondly, adipocytes and osteoblasts are derived from a common precursor, the mesenchymal stem cell; thus, molecules that activate osteoblast differentiation can inhibit adipogenesis [26] and vice versa. For example, a role of the Wnt pathway in these processes has been suggested in recent years [27] . Thirdly, excessive fat mass (especially visceral fat) is associated with increased proinflammatory cytokines [28] and reduced serum insulin-like growth factor I (IGF-I) levels [29] , which result in increased bone resorption and reduced bone formation. In addition, the changes in adipocyte-derived cytokines secretion in obesity such as increased production of leptin and decreased production of adiponectin could affect Fig. 1 The number of male and female participants in each fat mass index (FMI) category by body mass index (BMI) category bone formation [4] . Furthermore, excessive body fat is associated with lower vitamin D status [30] and increased parathyroid hormone concentration [31] ; both could have negative impact on BMD. We observed that the discordance between FMI and BMI was associated with lower BMD in women but not men. This could be because men with high body fat for BMI also had higher body weight than those with lower body fat for BMI ( Table 2 ), such that the positive effect of increased mechanical loading may have compensated for the negative impact of excess fat on bone metabolism. By contrast, in females, these two groups had similar body weight and BMI, further suggesting that those with high body fat for BMI had increased fat mass without an accompanying increase in lean mass. Indeed, as shown in Fig. 2 , a negative association of FMI with BMD at high FMI was observed in females but not males. As the women in the present study are at the age of peri-or postmenopausal, it is possible that the effect of high fat for BMI only becomes apparent when other factors such as oestrogen deficiency are driving bone loss [32] . In addition, men and women have different percentages of body fat (Table 1) , there were more very fat women than men (9.9 vs 6.8 % for obese II-III category using BMI cut-off) and both BMI and FMI explained a greater proportion of the variance in BMD in women than in men. These factors may explain the sex difference in our results.
None of the male participants and only 0.9 % of female participants were classified as underweight according to BMI. Thus, although low body weight in individuals is a risk factor for osteoporosis and fracture, this is not a common risk factor in this cohort. In contrast, using either BMI or FMI classification, there were about 30 % of the participants classified as obese in both male and female, confirming that obesity is a serious public health problem in this community. In addition, we found that 15 % of men and 20 % of women in the normal weight BMI category had excess body fat according to FMI categories. Ageing is associated with changes in body composition, with an increase in percentage body fat and reductions in lean mass and BMD, not necessarily accompanied by changes in weight or BMI [33] . It has been suggested that older people at greatest health risk are those who are simultaneously sarcopenic and obese [34] . In recent years, osteosarcopenic obesity, a condition of the simultaneous presence of osteopenia/osteoporosis, sarcopenia and increased adiposity, has received attention. Post-menopausal women classified as having osteosarcopenic obesity had been reported to have reduced functionality, which could lead to increased fracture risk [35] . Thus, the prevalence of osteoporosis in the obese population should receive greater attention, and there may be a value in increasing protein intake in combination with resistance training from middle age to preserve both lean body mass and bone mass with the aims of preventing agerelated bone loss and future fracture [36] . Strengths of our study include its large sample size and community-based nature, being representative of middleaged Australians in general [19] . The narrow age range of participants and the restriction of the analysis to Caucasians minimised the potential confounding effects of age and ethnicity on the evaluation of body fatness and BMD [37, 38] . Our study also has limitations. Firstly, it is observational and cross-sectional, and it cannot be assumed that the relationships demonstrated between BMI/FMI and BMD are causal in nature. A longitudinal study would be informative. It is possible that the discordance in BMI/FMI could be due to lifestyle factors such as diet and physical activity. We adjusted for age, physical activity levels and several important lifestyle factors, but as detailed dietary intakes were not recorded in the study, we only adjusted for dairy avoidance in the analysis, and the significant associations observed may still be due to potential residual or uncontrolled confounders. Secondly, the age restriction and ethnic homogeneity of the cohort means the results may not applicable to other age groups or ethnicities. However, middle-aged individuals such as baby boomers aged 45-67 are an important group to study, because agerelated changes in body composition are under way, and this group may respond to strategies to prevent age-related bone and muscle loss and future fracture. Thirdly, we used FMI cutoffs derived from an American study [16] . These have not been formally validated in Australians, but we think they are broadly applicable because the prevalence of overweight and obesity (BMI ≥ 25 kg/m 2 ) is similar for American nonHispanic whites [39] and Australians [40] in both men (80.8 vs 80.6 %) and women (61.3 vs 64.6 %) of similar age. FMI cut-offs are based on BMI, and further research is required to establish their relevance to clinical outcomes. Fourthly, the 95 % CIs in Fig. 2 are wider towards the high end of BMI and FMI due to the smaller number of subjects with BMI and FMI in that range. However, even if the subjects with very high BMI (>37.5 in males and >42.5 in females) and FMI (>12.5 in males and >22.5 in females) were excluded, the weaker association at high BMI and FMI would still be evident. It is known that measurement errors in BMD using DXA are larger in obese individuals, and in a recent study of healthy volunteers, fat layering significantly affected mean BMD values at the lumbar spine, but not at the femoral neck or total hip [41] .
In conclusion, our study showed that there were 12.9 % females and 13.2 % males in a higher FMI than BMI category (high body fat for BMI), whereas 9.8 % females and 15.6 % males were in a lower category (low body fat for BMI). We found that in women, but not men, who had high fat mass for BMI without an accompanying increase in lean mass, there was a decrease in BMD at the total hip, femoral neck and total body. Maintaining lean mass from middle age onwards may be important for the prevention of osteoporosis and associated fractures in later life.
